Clinical Trial Update: Non-Responsive Diabetic Macular Edema and Spironolactone [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating spironolactone for non-responsive diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Maculopathy

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Diabetic Maculopathy | Phase 4 | Status: WITHDRAWN